JORUVE Trademark

Trademark Overview

On Thursday, April 21, 2011, a trademark application was filed for JORUVE with the United States Patent and Trademark Office. The USPTO has given the JORUVE trademark a serial number of 85301393. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 15, 2014. This trademark is owned by Glaxo Group Limited. The JORUVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
joruve

General Information

Serial Number85301393
Word MarkJORUVE
Filing DateThursday, April 21, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 15, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 25, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiddlesex UB060NN

Trademark Events

Event DateEvent Description
Monday, September 15, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 15, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 18, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, February 15, 2014EXTENSION 5 GRANTED
Thursday, February 6, 2014EXTENSION 5 FILED
Thursday, February 6, 2014TEAS EXTENSION RECEIVED
Friday, August 2, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2013EXTENSION 4 GRANTED
Tuesday, July 30, 2013EXTENSION 4 FILED
Tuesday, July 30, 2013TEAS EXTENSION RECEIVED
Thursday, June 6, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 6, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 24, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 23, 2013EXTENSION 3 GRANTED
Thursday, January 17, 2013EXTENSION 3 FILED
Thursday, January 17, 2013TEAS EXTENSION RECEIVED
Tuesday, August 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 13, 2012EXTENSION 2 GRANTED
Friday, July 27, 2012EXTENSION 2 FILED
Monday, August 13, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 27, 2012TEAS EXTENSION RECEIVED
Wednesday, January 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 16, 2012EXTENSION 1 GRANTED
Monday, January 16, 2012EXTENSION 1 FILED
Monday, January 16, 2012TEAS EXTENSION RECEIVED
Tuesday, August 9, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2011PUBLISHED FOR OPPOSITION
Monday, May 9, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 5, 2011ASSIGNED TO LIE
Thursday, May 5, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 5, 2011EXAMINER'S AMENDMENT ENTERED
Thursday, May 5, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 5, 2011EXAMINERS AMENDMENT E-MAILED
Thursday, May 5, 2011EXAMINERS AMENDMENT -WRITTEN
Saturday, April 30, 2011ASSIGNED TO EXAMINER
Monday, April 25, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 25, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

joruve pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological